ATE341318T1 - Verwendung eines mittels zur verbesserung der astrozytenfunktion zur behandlung von parkinsons krankheit - Google Patents
Verwendung eines mittels zur verbesserung der astrozytenfunktion zur behandlung von parkinsons krankheitInfo
- Publication number
- ATE341318T1 ATE341318T1 AT01117308T AT01117308T ATE341318T1 AT E341318 T1 ATE341318 T1 AT E341318T1 AT 01117308 T AT01117308 T AT 01117308T AT 01117308 T AT01117308 T AT 01117308T AT E341318 T1 ATE341318 T1 AT E341318T1
- Authority
- AT
- Austria
- Prior art keywords
- agent
- disease
- astrocyte function
- treat parkinson
- improving
- Prior art date
Links
- 210000001130 astrocyte Anatomy 0.000 title abstract 3
- 208000018737 Parkinson disease Diseases 0.000 title abstract 2
- 206010034010 Parkinsonism Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000216763 | 2000-07-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE341318T1 true ATE341318T1 (de) | 2006-10-15 |
Family
ID=18711968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01117308T ATE341318T1 (de) | 2000-07-18 | 2001-07-17 | Verwendung eines mittels zur verbesserung der astrozytenfunktion zur behandlung von parkinsons krankheit |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7019032B2 (de) |
| EP (1) | EP1174131B1 (de) |
| KR (1) | KR100759771B1 (de) |
| CN (1) | CN1179722C (de) |
| AT (1) | ATE341318T1 (de) |
| AU (1) | AU780328B2 (de) |
| BR (1) | BR0102940A (de) |
| CA (1) | CA2353205C (de) |
| DE (1) | DE60123528T2 (de) |
| DK (1) | DK1174131T3 (de) |
| ES (1) | ES2272383T3 (de) |
| HU (1) | HUP0102987A3 (de) |
| MX (1) | MXPA01007210A (de) |
| NO (1) | NO20013544L (de) |
| NZ (1) | NZ513040A (de) |
| PT (1) | PT1174131E (de) |
| RU (1) | RU2275906C2 (de) |
| TW (1) | TWI290831B (de) |
| ZA (1) | ZA200105886B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100759771B1 (ko) * | 2000-07-18 | 2007-10-04 | 오노 야꾸힝 고교 가부시키가이샤 | 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제 |
| US7928143B2 (en) | 2003-10-03 | 2011-04-19 | Ono Pharmaceutical Co., Ltd. | Method for preventing and/or treating neurodegenerative diseases |
| US8053599B2 (en) * | 2003-10-03 | 2011-11-08 | Ono Pharmaceutical Co., Ltd. | Drug containing (2R)-2-propyloctanoic acid as the active ingredient |
| WO2005032537A1 (en) * | 2003-10-03 | 2005-04-14 | Ono Pharmaceutical Co., Ltd. | Method for preventing and/or treating neurodegenerative diseases |
| MXPA06003605A (es) * | 2003-10-03 | 2006-06-14 | Ono Pharmaceutical Co | Preparacion de infusion que contiene acido (2r)-2-propiloctanoico como ingrediente activo. |
| WO2005105722A1 (ja) * | 2004-04-28 | 2005-11-10 | Ono Pharmaceutical Co., Ltd. | (２ｒ)−２−プロピルオクタン酸とアミンとからなる結晶 |
| TW200613009A (en) * | 2004-06-11 | 2006-05-01 | Ono Pharmaceutical Co | Capsule having chewing stability |
| ES2384034T3 (es) | 2006-03-09 | 2012-06-28 | Ono Pharmaceutical Co., Ltd. | Agente terapéutico para una enfermedad cerebral funcional |
| US20110112010A1 (en) * | 2008-02-15 | 2011-05-12 | The Government of the United States of America, as represented by The National Institutes of Health | Octanoic acid formulations and methods of treatment using the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3769424A (en) * | 1970-10-01 | 1973-10-30 | Merck & Co Inc | Composition and method of treating dopamine deficiency in brain tissue |
| HU209564B (en) * | 1991-01-30 | 1994-07-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing rapide tablets containing levodopa and carbidopa |
| TW248552B (de) * | 1993-06-01 | 1995-06-01 | Onoda Yakuhin Kogyo Kk | |
| US5672746A (en) * | 1994-08-30 | 1997-09-30 | American Biogenetic Sciences, Inc. | Antiproliferative and neurotrophic molecules |
| KR100759771B1 (ko) * | 2000-07-18 | 2007-10-04 | 오노 야꾸힝 고교 가부시키가이샤 | 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제 |
-
2001
- 2001-07-13 KR KR1020010042232A patent/KR100759771B1/ko not_active Expired - Fee Related
- 2001-07-16 MX MXPA01007210A patent/MXPA01007210A/es active IP Right Grant
- 2001-07-17 RU RU2001119914/15A patent/RU2275906C2/ru not_active IP Right Cessation
- 2001-07-17 NO NO20013544A patent/NO20013544L/no not_active Application Discontinuation
- 2001-07-17 ZA ZA200105886A patent/ZA200105886B/xx unknown
- 2001-07-17 BR BR0102940-1A patent/BR0102940A/pt not_active Application Discontinuation
- 2001-07-17 HU HU0102987A patent/HUP0102987A3/hu unknown
- 2001-07-17 US US09/906,065 patent/US7019032B2/en not_active Expired - Fee Related
- 2001-07-17 DE DE60123528T patent/DE60123528T2/de not_active Expired - Lifetime
- 2001-07-17 PT PT01117308T patent/PT1174131E/pt unknown
- 2001-07-17 EP EP01117308A patent/EP1174131B1/de not_active Expired - Lifetime
- 2001-07-17 AT AT01117308T patent/ATE341318T1/de active
- 2001-07-17 DK DK01117308T patent/DK1174131T3/da active
- 2001-07-17 CA CA002353205A patent/CA2353205C/en not_active Expired - Fee Related
- 2001-07-17 ES ES01117308T patent/ES2272383T3/es not_active Expired - Lifetime
- 2001-07-18 NZ NZ513040A patent/NZ513040A/xx unknown
- 2001-07-18 TW TW090117513A patent/TWI290831B/zh not_active IP Right Cessation
- 2001-07-18 CN CNB011233745A patent/CN1179722C/zh not_active Expired - Fee Related
- 2001-07-18 AU AU54464/01A patent/AU780328B2/en not_active Ceased
-
2005
- 2005-09-01 US US11/216,114 patent/US20060052453A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20020007188A (ko) | 2002-01-26 |
| NO20013544D0 (no) | 2001-07-17 |
| MXPA01007210A (es) | 2004-10-29 |
| CN1334081A (zh) | 2002-02-06 |
| NZ513040A (en) | 2003-02-28 |
| US20060052453A1 (en) | 2006-03-09 |
| PT1174131E (pt) | 2007-01-31 |
| CA2353205C (en) | 2008-10-07 |
| US20020032185A1 (en) | 2002-03-14 |
| TWI290831B (en) | 2007-12-11 |
| ES2272383T3 (es) | 2007-05-01 |
| HUP0102987A3 (en) | 2003-02-28 |
| DE60123528T2 (de) | 2007-02-15 |
| BR0102940A (pt) | 2002-03-05 |
| HUP0102987A2 (hu) | 2002-04-29 |
| RU2275906C2 (ru) | 2006-05-10 |
| US7019032B2 (en) | 2006-03-28 |
| CN1179722C (zh) | 2004-12-15 |
| KR100759771B1 (ko) | 2007-10-04 |
| NO20013544L (no) | 2002-01-21 |
| HU0102987D0 (en) | 2001-09-28 |
| AU5446401A (en) | 2002-01-24 |
| DE60123528D1 (de) | 2006-11-16 |
| CA2353205A1 (en) | 2002-01-18 |
| AU780328B2 (en) | 2005-03-17 |
| DK1174131T3 (da) | 2007-02-05 |
| ZA200105886B (en) | 2002-01-17 |
| EP1174131B1 (de) | 2006-10-04 |
| EP1174131A1 (de) | 2002-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110969T1 (el) | 5-υποκατεστημενα-2-φαινυλαμινο-βενζαμιδια ως αναστολεiς μεκ | |
| CY1111951T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| ATE396174T1 (de) | Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| ATE184483T1 (de) | Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms | |
| ATE341318T1 (de) | Verwendung eines mittels zur verbesserung der astrozytenfunktion zur behandlung von parkinsons krankheit | |
| DE3888340D1 (de) | Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit. | |
| RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
| DE69929362D1 (de) | verwendung von 1,4-benzothiazepinen zur Herstellung eines Medikaments ZUR BEHANDLUNG DER VORHOF-FIBRILLATION | |
| DE60239165D1 (de) | Perkutane absorptionszubereitungen mit 3-methyl-1-phenyl-2-pyrazolin-5-on | |
| DE602004019778D1 (de) | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen | |
| SG146685A1 (en) | Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
| ATE511395T1 (de) | Mittel zur behandlung von glomerulopathie | |
| EP1325918A4 (de) | Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten | |
| DE60143671D1 (de) | Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor-antagonists | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| DE69910706D1 (de) | Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| ATE554787T1 (de) | Behandlung von typ-1-diabetes vor und nach der expression von prädispositionsmarkern | |
| DE69532963D1 (de) | Verwendung von 4-acylaminopyridin derivaten zur Herstellung eines Medikaments für die Behandlung von zerebrovaskulären Erkrankungen | |
| ATE175351T1 (de) | Therapeutisches mittel zur behandlung von ischämischen oder reperfusion schädigungen des myokards | |
| ATE64095T1 (de) | Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. | |
| ATE199318T1 (de) | Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms | |
| ATE360432T1 (de) | Peptid zur behandlung von nervenerkrankungen | |
| ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1174131 Country of ref document: EP |